In Philly, We Believe Harm Reduction Saves Lives
Substance Use Prevention and Harm Reduction (SUPHR) is a division of the Philadelphia Department of Public Health.
By promoting the dignity, autonomy, and health of people who use drugs, we work to prevent drug-related deaths and the potential harms associated with drug use.
Learn more about SUPHR ⟶
-
![]()
2025 drug checking reporting finds medetomidine present in nearly 80% of Philly dope samples
-
![]()
In 2023, fatal overdoses decreased by 7%. Read the 2022-2023 annual report.
-
![]()
New toolkit provides guidance for xylazine-associated wound care
-
![]()
A new hazardous industrial chemical, BTMPS, has been detected in the drug supply.
-
![]()
A new non-opioid veterinary sedative, medetomidine, entered the drug supply.
-
![]()
The X-Waiver is no longer required for DEA registered providers to prescribe buprenorphine.
